Oncology
Content related to Oncology:
ESMO 2016: New data from Eisai’s oncology portfolio for halaven (eribulin), lenvima (lenvatinib) and kisplyx (lenvatinib)
By Niamh Louise Marriott, Digital Content Producer
Bristol-Myers Squibb and Nektar Therapeutics to combine oncology therapies
By Niamh Louise Marriott, Digital Content Producer
Initiation of HTL1071 trial triggers $10m payment to Heptares
By Victoria White, Digital Content Producer
Positive results for Yeliva in Phase I advanced solid tumour study
By Victoria White, Digital Content Producer
Xilonix demonstrates significant clinical response in colorectal cancer study
By Victoria White, Digital Content Producer
BMS and PsiOxus to evaluate Opdivo and enadenotucirev in cancer
By Victoria White, Digital Content Producer
Global urological cancers market to double by 2022, says GBI Research
By Victoria White, Digital Content Producer
Regorafenib increases overall survival in hepatocellular carcinoma study
By Victoria White, Digital Content Producer
Novartis and Xencor enter bispecific antibody collaboration
By Victoria White, Digital Content Producer
Cancer immunotherapy drugs linked to autoimmune diseases
By Victoria White, Digital Content Producer
Phase I/II trial of INCAGN1876 in solid tumours starts
By Victoria White, Digital Content Producer
Denosumab may prevent breast cancer in women with BRCA1 gene mutation
By Victoria White, Digital Content Producer
Chemo may boost immunotherapy power in ovarian cancer
By Victoria White, Digital Content Producer
Tecentriq to dominate the bladder cancer market, says GlobalData
By Victoria White, Digital Content Producer
Follow: